Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000218

EVP, Chief Business Officer sold 5,635 shares at $80.16 ($451,699)

  • EVP, Chief Business Officer acquired 5,635 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Baroldi Joseph · EVP, Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-26 Exercise or conversion : show line 1 in the form 10b5-1 +3,866 $56.78 $219,511 8,535 I
2026-06-26 Exercise or conversion : show line 2 in the form 10b5-1 +1,769 $32.60 $57,669 10,304 I
2026-06-26 Sale : show line 3 in the form 10b5-1 −5,635 $80.16 $451,699 4,669 I
Open-market sales · 5,635 sh · avg $80.16 · $451,699

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-26 Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −1,769 0 I
2026-06-26 Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −3,866 0 I
Loading xslF345X06/edgardoc.xml…